Cybin Corp. CEO Discusses Ongoing Efforts to Develop One of the First Commercially Approved Psychedelic Medications for Mental Health

Ads

You May Also Like

APHL Announces Newborn Screening Funding Recipients

Silver Spring, MD, Dec. 19, 2017 (GLOBE NEWSWIRE) -- For Immediate Release The Association of ...

Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017

Positive CHMP Opinion for Lutetium Lu 177 Dotatate* (Lutathera®) for GEP-NETS FDA Acknowledged Receipt ...

Fluidigm Announces Second Quarter 2018 Financial Results

Total revenue increases 11 percent to $26.4 million Mass cytometry revenue growth of 32 ...